Ausgabe 2/2012
Inhalt (21 Artikel)
short review
Immunotherapy for nonsmall-cell lung cancer
Astrid Belalcazar, Luis E. Raez, Edgardo S. Santos
short review
Immunotherapeutic approaches targeting prostate cancer and its microenvironment
Robert Zeiser
short review
Natural killer cell based immunotherapy for eradication of minimal residual disease in patients with malignant disorders
Panagiotis D. Tsirigotis, Nikolaos Papanikolaou
short review
The role of biomarkers in the choice of therapy in breast cancer
Brigitte Mlineritsch, Sigrun Ressler, Richard Greil
review
Evolving strategies to overcome endocrine resistance in breast cancer
Michael Hubalek, Christine Brunner, Christian Marth
short review
Surgical removal of the primary?—The role it plays in stage IV breast cancer
Florian Fitzal
short review
The role of Positron Emission Tomography/Computer Tomography (PET/CT) in the diagnosis, staging, characterization, and therapy of breast cancer
Zoltán Lőcsei, Katalin Hideghéty, Zsuzsanna Kahán
short review
Breast cancer: is there a need for biopsy of metastases?
Flora Zagouri, Martin Filipits
short review
Advanced breast cancer: new imaging techniques for detection of metastases
Helmut Schoellnast, Christian Gstettner
original report
Treatment outcome in AML: a single-centre experience in an unselected patient cohort
Kathrin Strasser-Weippl, Martin Schreder, Niklas Zojer, Heinz Ludwig
case report
Sjögren syndrome complicated with hairy-cell leukemia: a case-based review
Noushin Bayat, Hasan Bagheri, Reza Karbasi-Afshar, Alireza Saadat, Farhad Sarrafzadeh, Amin Saburi
short review
Lung cancer screening: current evidence and recommendations
Michael Mark, Martin Brutsche, Oliver Gautschi
case report
Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer?
Ulf Petrausch, Verena Tischler, Walter Weder, Rolf Stahel, Alex Soltermann
short review
Recent advances and future challenges in the treatment of upper gastrointestinal malignancies
Dieter Koeberle, Anna Dorothea Wagner
comment
Advances in haematology and oncology 2011: hepatocellular carcinoma (HCC)
Markus Peck-Radosavljevic
short review
Highlights in the adjuvant treatment of colon cancer from annual meetings 2011
Gudrun Resch, Josef Thaler